Fontan Procedure Clinical Trial
Official title:
Cardiopulmonary Adaptation of Short Term Exposure to High Altitude in Fontan Patients: Swiss Fontan & ALtitude COllaboratioN (FALCON) Study
Important advances in cardiac surgery, intensive care, and diagnostic modalities over the last decades have led to a steady growth in the number of adults with congenital heart defects. Among adults with congenital heart disease, patients with a Fontan circulation typically show the lowest values of peak oxygen consumption. For these patients, strict exclusion from activities at high altitude may have an impact on quality of life. The investigators aim to elucidate the short term effects of a stay at high altitude on hemodynamic adaptation, exercise capacity and clinical well being in adult Fontan patients. The investigators hypothesize that patients with a Fontan circulation in NYHA functional class I-II are able to increase their cardiac output during exercise at high altitude in order to meet the required metabolic demands and therefore tolerate the journey to the Jungfraujoch well.
Background:
Important advances in cardiac surgery, intensive care, and diagnostic modalities over the
last decades have led to a steady growth in the number of adults with congenital heart
defects (Grown-up congenital heart disease GUCH). Among adults with congenital heart
disease, patients with a Fontan circulation typically show the lowest values of peak oxygen
consumption with peak VO2 values between 15 and 29 ml/kg/min, corresponding to 43-64 % of
the predicted values in healthy controls. For these patients, strict exclusion from
activities at high altitude may have an impact on quality of life. Unfortunately, the most
recent recommendations for physical activity, recreation sport, and exercise training in
paediatric patients with congenital heart disease do not provide specific recommendations.
The investigators study therefore aims to elucidate the short term effects of a stay at high
altitude on hemodynamic adaptation, exercise capacity and clinical well being in adult
Fontan patients. These results are necessary to counsel GUCH patients with respect to their
leasure activities in Switzerland.
Objective:
The aims of the study are to measure a)the hemodynamic adaptation (pulmonary blood flow) at
rest and during exercise; b)the response of cardiopulmonary parameters to exercise
(ventilation, O2 uptake) and c) heart rate variability and occurrence of arrhythmias during
the journey and while performing study measures in patients with a Fontan circulation. The
measurements will be performed at high altitude and at lowland and compared with an age- and
gender-matched control group of healthy subjects. The objective is to test the clinical
tolerance of high altitude exposure after a rapid ascent with public transport in patients
with a Fontan circulation. The investigators hypothesize that patients with a Fontan
circulation in NYHA functional class I-II are able to increase their cardiac output during
exercise at high altitude in order to meet the required metabolic demands despite hypoxia
induced pulmonary vasoconstriction and therefore tolerate the journey to the Jungfraujoch
well.
Methods:
The investigators aim to include 30 patients with a Fontan circulation and 30 age and
gender-matched healthy adults. Baseline testing in Bern (540m over sea level)includes: a
symptom limited cardiopulmonary exercise stress test on a cycle ergometer with a ramp
protocol (CPX); a pulmonary function test (spirometry); a symptom limited, stepwise
increasing workload test with non-invasive inert gas rebreathing method for pulmonary blood
flow measurement during exercise (Innocor®); analysis of heart rate variability (HRV);
Holter-ECG monitoring for detection of arrhythmias.
Within a time period of 12 weeks, the baseline tests will be repeated on the Jungfraujoch
(3454m).
The primary endpoint of this study is the increase of pulmonary blood flow during exercise
in response to high altitude exposure.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05063903 -
Exercise Capacity in Patients With Fontan Procedure
|
||
Terminated |
NCT01107990 -
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
|
||
Not yet recruiting |
NCT06193863 -
An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure
|
||
Completed |
NCT03726229 -
Cholate Clearance in Fontans
|
||
Completed |
NCT00974025 -
Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated Patients
|
N/A | |
Completed |
NCT05011565 -
Hemodynamic, Vascular and Muscular Parameters of Exercise Capacity in Single-Ventricle Patients With Fontan Procedure
|
||
Recruiting |
NCT05684562 -
Pulmonary Determinants of Cardiorespiratory Fitness in Fontan Patients
|
||
Terminated |
NCT02966002 -
Aspirin as a Novel Anti-Inflammatory Modality in the Fontan Patients
|
Phase 4 | |
Completed |
NCT03503032 -
Clinical Outcomes in Fenestrated Extra-Cardiac Fontan in Low Preoperative Risk Profiles
|